Sarepta Therapeutics, Inc. (SRPT) free cash flow

Free cash flow · fiscal 2025
-$315.33M

Sarepta Therapeutics, Inc. (SRPT) generated free cash flow of -$315.33M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$352.74M. Figures as of 18 Nov 2026, 12:19 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
-$315.33M
Highest on record
$25.26Mfiscal 2020
Lowest on record
-$588.34Mfiscal 2023
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Sarepta Therapeutics, Inc. free cash flow, in more detail

Across the 17 fiscal years on record (2009–2025), the highest was $25.26M in fiscal 2020 and the lowest -$588.34M in fiscal 2023.

History · 17 fiscal years

Free cash flow by fiscal year

Sarepta Therapeutics, Inc. free cash flow, year by year

Sarepta Therapeutics, Inc. (SRPT) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025-$315.33M—
2024-$352.74M—
2023-$588.34M—
2022-$357.60M—
2021-$481.66M 2,006.5% down
2020$25.26M—
2019-$516.09M—
2018-$449.82M—
2017-$244.00M—
2016-$251.16M—
2015-$152.87M—
2014-$153.98M—
2013-$67.07M—
2012-$29.80M—
2011-$24.86M—
2010-$16.04M—
2009-$9.73M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

More on SRPT

Sarepta Therapeutics, Inc., figure by figure

Sarepta Therapeutics, Inc. (SRPT) overview: price, valuation and scorecard

Sarepta Therapeutics, Inc. free cash flow: questions and answers

What is Sarepta Therapeutics, Inc.'s free cash flow?

Sarepta Therapeutics, Inc. (SRPT) generated free cash flow of -$315.33M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$352.74M.

What are the highest and lowest free cash flow figures on record for Sarepta Therapeutics, Inc.?

Across the 17 fiscal years on record (2009–2025), the highest was $25.26M in fiscal 2020 and the lowest -$588.34M in fiscal 2023.

How is Sarepta Therapeutics, Inc.'s free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Sarepta Therapeutics, Inc. it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Sarepta Therapeutics, Inc. (SRPT) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/SRPT/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.